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Background/aim: The aim of this study was to compare the effect of salbutamol delivered to children by jet nebulizer (JN) and mesh
nebulizer (MN).
Materials and methods: Children admitted with acute asthma were treated with 3 doses of nebulized salbutamol, 1 given by MN. The
patients’ vital signs, lung function measurements, modified pulmonary index score (MPIS), and whole body plethysmography (WBP)
measurements were evaluated before and 20 min after each dose of salbutamol.
Results: Thirty-one children [9.5 (6.4–17.2) years, 67.7% male, 32.3% female] with mild (67.7%) and moderate (32.3%) asthma attacks
were included in the study. The improvements with MN were comparable with JN in terms of changes in pretreatment and posttreatment
forced expiratory volume in the first second (FEV1) (2.57 ± 4.57, 3.65 ± 5.44; P = 0.44), forced vital capacity (FVC) (2.52 ± 5.29, 4.17 ±
7.54; P = 0.28), heart rate (7.33 ± 10.21, 4.14 ± 9.32; P = 0.24), peripheral capillary oxygen saturation (SpO2) (0.38 ± 0.23, 0.43 ± 0.15;
P = 0.83), and modified pulmonary index score (MPIS) (−6.30 ± 22.70, −8.77 ± 25.46; P = 0.70). The pre- and posttreatment values of
total lung capacity (TLC), residual volume (RV), specific conductance (sGaw), and RV/TLC were similar for the JN and MN groups.
Adverse effects were not different: however, complaints of palpitation were significantly higher in the posttreatment MN group than the
pretreatment MN group (32.3% vs 9.7%, respectively, P = 0.016).
Conclusions: These findings support the previous evidence found in studies of adults that MN is as effective as and as safe as JN in the
treatment of acute asthma in children.
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1. Introduction
In the treatment of acute severe asthma, inhalation therapy
through nebulizers is essential. Nebulizers are devices
that convert liquid formulations into gaseous suspended
droplets. There are 3 types of nebulizers that have different
working principles currently in use: jet, ultrasonic, and
mesh nebulizers. Jet nebulizers (JN) are in widespread use
for the treatment of acute asthma in daily practice, since
they are less expensive, less fragile, and have a smaller
average particle size than ultrasonic nebulizers. However,
ultrasonic nebulizers have a higher output rate and do
not increase drug concentration as much as JN, but may
cause drug degradation, and do not nebulize suspensions
well [1]. Recently, several electronic nebulizer devices that
use a vibrating mesh or plate have been marketed, and
these devices have been suggested to be more efficient at
delivering aerosol to the lung. Mesh nebulizers (MN) have
the advantages of being quieter, lighter, portable, suitable

for use in a horizontal position, and with no need for a
continuous electric supply. Despite the limited number of
studies reporting a comparable effect with JN, there is no
consensus on which nebulizer is more appropriate for the
treatment of acute asthma or which is better for certain
subgroups of children [2,3].
We have therefore undertaken a randomized, singleblind clinical trial to compare the effect of salbutamol
delivered by JN and MN on clinical and lung function
parameters in children with mild/moderate acute asthma.
The primary outcome goal was to evaluate whether
nebulized salbutamol via 2 different nebulizers provides
similar benefit to forced expiratory volume in the first
second (FEV1). Secondary outcomes included changes to
peripheral capillary oxygen saturation (SpO2), modified
pulmonary index score (MPIS), forced vital capacity
(FVC), FEV1/FVC, total lung capacity (TLC), residual
volume (RV), RV/TLC, specific conductance (sGaw),
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and frequency of adverse effects (palpitation, shivering,
tremor, and flushing).
2. Materials and methods
This prospective study was performed in a tertiary
pediatric allergy department between 2015 and 2018. The
patients between the ages of 6 and 18 years who presented
with mild-to-moderate acute asthma and were cooperative
for performance of lung function tests (LFT) and whole
body plethysmography (WBP) were included. Acute
asthma was defined as an increase in symptoms, such as
cough, wheezing, shortness of breath or chest tightness,
and beta2-agonist use [4]. Severity of acute asthma was
evaluated based on the 6 variables of the MPIS: heart
rate, respiratory rate, inspiratory-to-expiratory flow ratio,
accessory muscle use, degree of wheezing, and oxygen
saturation in room air [5,6]. The patients who had used
long-acting bronchodilators within the last 12 h or shortacting bronchodilators within the last 2 h were excluded.
History of chronic disease, having the signs of respiratory
failure, admission to an intensive care unit in the last
year and/or hospitalization history in the last 6 months,
and having a contraindication for a lung function test
(LFT), such as pneumothorax, were the exclusion criteria.
Hacettepe University Institutional Review Board approved
the study (KA14012/685), and only patients and their
parents who gave written informed consent were included.
2.1. Study design
To document whether different nebulizers have comparable
efficacy and safety, mesh (Omron NE-U22-E, Kyoto, Japan)
and jet (Omron NE-C28-P, Kyoto, Japan) nebulizers were
compared in this participant-blinded study. The children
admitted with acute asthma were treated with 3 repetitive
doses of nebulized salbutamol given every 20 min. Only
one of the doses was given with MN, and as either the
second or third dose. Pooled analysis was performed for
the second and third doses according to the type of the
nebulizer. Figure represents the scheme of the study.
The data collected on admission included demographics
and asthma-specific characteristics. The patients’ vital
signs, SpO2, lung function measurements, and MPIS were
evaluated before and 20 min after each dose of salbutamol.
Salbutamol was administered to all patients as a 0.15 mg/

Jet nebulizer
n=31

Mesh nebulizer
n=17

Jet nebulizer

Jet nebulizer
n=14

Mesh nebulizer

Figure. Scheme of the study.

kg/dose (max. 5mg) every 20 min using the nebulizer with
a face mask. Physicians followed the recommendations of
the Global Initiative for Asthma (GINA) guidelines for
acute asthma treatment [4].
Lung function parameters were measured at admission
and 20 min after each dose of salbutamol with a spirometer
(ZAN100 spirometry system, nSpire Health, Longmont,
CO, USA), including FVC, FEV1, FEV1/FVC, TLC, RV,
RV/TLC, sGaw, and whole body plethysmography (WBP)
(SensorMedics 2130 & 6200 Autobox, SensorMedics,
Anaheim, CA, USA) .
2.2. Statistical analysis
The descriptive data for categorical variables were expressed
as frequencies and percentages for continuous variables
and as means and standard deviations (SD) or medians
and interquartile ranges, according to the distribution
of variables, as appropriate. For categorical variables, the
chi-square test was used to compare groups, McNemar
and Cochran Q-tests were used for dependent variables.
Group comparisons for variables that were not distributed
normally were carried out with the Mann–Whitney U test
or the Kruskal–Wallis test, and the Wilcoxon signed-ranks
test and Friedman tests were used for dependent variables.
A P-value of less than 0.05 was considered statistically
significant. All analyses were performed using IBM SPSS
Statistics 22.0 for Windows (IBM Corporation, Armonk,
NY, USA).
3. Results
We included 31 children (67.7% male, 32.3% female) with a
median age of 9.5 years (6.4–17.2 years). The characteristics
of the patients are summarized in Table 1. Twenty-three
Table 1. Characteristics of the study population (n = 31).
Male (n,%)

21 (67.7)

Age (year) *

9.5 (6.4–17.2)

Onset of asthma symptoms (year)

3.64 ± 2.89

Age of asthma diagnosis (year)

4.88 ± 3.37

Atopy n (%)
Pollen
Dust mites
Animal dander
Mold
Food

18 (58)
12 (38.7)
8 (25.8)
1 (3.2)
5 (16.1)
1 (3.2)

Comorbidity n (%)
Allergic rhinitis
Obesity
Chronic sinusitis
Adenoid vegetation
Allergic rhinitis+obesity

15 (48.4)
10 (32.3)
2 (6.5)
1 (3.2)
1 (3.2)
1 (3.2)

*median (interquartile range)
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(74.2%) patients were on prophylactic asthma medications,
and 21 (67.7%) of them were using inhaled corticosteroids
with a median duration of 9 months (1–36 months). At
admission, 21 (67.7%) patients were classified as having
mild exacerbation and the remaining (32.3%) as moderate
exacerbation according to MPIS scores. Lung functions,
including FEV1 and SpO2, significantly improved after 3
doses of beta2-agonist inhalation (Table 2). At admission,
the mean FEV1 value was 66.66 (±17.62). The mean MPIS
value at admission was 7 (± 0.39) and decreased to 5.22
(±0.41) after 3 doses of salbutamol (Table 2). Six patients
(19.4%) required systemic corticosteroids after 3 doses
beta2-agonist inhalation.
The MN group was comparable with the JN group in
pretreatment FEV1, posttreatment FEV1, change in FEV1,
pre and posttreatment FVC, FEV1/FVC, heart rate, SpO2,
and pre- and posttreatment MPIS (Table 3). There was
no difference in FEV1 and MPIS pre- and posttreatment
in either group. The SpO2 before and after treatment was
>95% in all patients and no significant changes were seen
after treatment in both groups (P = 0.828, Table 4). TLC,
RV, sGaw, and RV/TLC were measured by WBP and the
results were similar for both groups (Table 3). Adverse
effects were not different between JN and MN groups
except palpitation (Table 4). Complaint of palpitation was
significantly higher in the posttreatment MN group than
the pretreatment MN group (32.3% vs 9.7%, respectively,
P = 0.016).
4. Discussion
To our knowledge, this is the first single blind crossover
study in the literature comparing the effects of jet and

mesh nebulizers on measures of spirometry and body
plethysmography in children with mild/moderate acute
asthma. Our findings support the previous evidence found
in studies of adults that MN is as effective and safe as JN
when used in the treatment of acute asthma in children.
Jet nebulizers are easy to use and inexpensive, so they
are commonly used in clinical practice. However, they
have a large residual solution volume that cannot nebulize
the last of the dose, require an electric source, and cannot
be used in a horizontal position. Because of the limitations
of JNs, new nebulizers have been developed such as MNs.
Compared with JN, MN has high aerosol generation
ability and a low residual nebulizer-solution volume, so it
can nebulize even µL volumes [7]. There are quite a few
studies comparing the efficiency of jet and mesh nebulizers
in childhood asthma.
Adachi et al. studied 73 children with asthma (34
children with mild asthma exacerbation, 39 children
in stable condition) who were given a short-acting
bronchodilator, procaterol, with conventional and mesh
nebulizers. Similar results were observed with both types
of nebulizer in terms of the patients’ physical examinations,
pulmonary function tests, and side effects. However, the
mesh nebulizer was found to have a shorter inhalation
time. They concluded that the shorter inhalation time may
be an advantage for children who develop a bad temper
during inhalation therapy [8]. In another study, pediatric
asthma patients aged 8–13 years were randomly divided
into 3 groups to compare 3 different mesh nebulizers.
Although some differences in lung function improvement
had been detected, all 3 mesh nebulizers were found to be
useful devices in treating bronchial asthma [9]. A clinical

Table 2. Clinical and lung function parameters of the patients at admission and after
treatment.
Admission

After 3 doses of
salbutamol

P

FEV1 (%) predicted

66.66 ± 17.62

84.87 ± 16.28

<0.001

FVC (%) predicted

72.96 ± 17.43

87.09 ± 14.66

<0.001

FEV1/FVC

97.03 ± 14.07

102.90 ± 9.63

0.004

Sp02 (%)

96.29 ± 1.37

97.09 ± 0.97

<0.010

MPIS

7 ± 2.2

5.22 ± 2.33

<0.003

TLC (%) predicted

114.20 ± 17.78

113.76 ± 14.62

0.862

RV (%) predicted

219 ± 81.85

196.83 ± 57.98

0.105

SGaw (%) predicted

62.50 ± 38.21

113.34 ± 66.19

0.001

RV/TLC (Lt)

0.40 ± 0.11

0.36 ± 0.09

0.010

Abbreviations: FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; SpO2,
peripheral capillary oxygen saturation; MPIS, modified pulmonary index score; TLC,
total lung capacity; RV, residual volume; SGaw, Specific airway conductance

1010

SOYER et al. / Turk J Med Sci
Table 3. Comparison of mesh and jet nebulizer study groups by spirometer WBP
measurements.
Mesh nebulizer

Jet nebulizer

P

FEV1
Pre (%) (Mean ± SD)
Post (%) (Mean ± SD)
% Change

81.00 ± 15.10
83.12 ± 16.10
2.57 ± 4.57

81.29 ± 16.34
84.00 ± 15.83
3.65 ± 5.44

0.941
0.827
0.442

FVC
Pre (%) (Mean ± SD)
Post (%) (Mean ± SD)
% Change

82.61 ± 15.84
84.51 ± 15.97
2.52 ± 5.29

83.00 ± 16.13
85.8 ± 14.40
4.17 ± 7.54

0.925
0.735
0.276

FEV1/FVC
Pre (%) (Mean ± SD)
Post (%) (Mean ± SD)
% Change

103.12 ± 8.05
104.12 ± 7.93
1.05 ± 3.63

103.67 ± 8.51
103.29 ± 9.54
0.34 ± 5.99

0.816
0.725
0.217

MPIS
Pre (%) (Mean ± SD)
Post (%) (Mean ± SD)
% Change

5.80 ± 2.45
5.38 ± 2.31
−6.30 ± 22.70

6.00 ± 2.06
5.45 ± 2.41
−8.77 ± 25.46

0.733
0.923
0.706

Heart Rate
Pre (%) (Mean ± SD)
Post (%) (Mean ± SD)
% Change

110.00 ± 17.33
118.03 ± 21.17
7.33 ± 10.21

111.87 ± 18.92
116.22 ± 20.41
4.14 ± 9.32

0.709
0.761
0.247

Sp02
Pre(%) (Mean ± SD)
Post (%) (Mean ± SD)
% Change

96.5 ± 0.24
96.87 ± 0.18
0.38 ± 0.23

96.5 ± 0.25
96.9 ± 0.23
0.43 ± 0.15

1.000
0.778
0.836

TLC
Pre(%) (Mean ± SD)
Post (%) (Mean ± SD)
% Change

115.63 ± 15.93
111.63 ± 13.86
−2.96 ± 8.22

111.06 ± 15.14
116.00 ± 14.66
5.42 ± 14.42

0.313
0.204
0.008

208.86 ± 68.23
188.16 ± 55.35
−6.43 ± 24.9

187.70 ± 68.64
207.20 ± 67.62
24.89 ± 83.52

0.277
0.147
0.054

sGaw
Pre(%) (Mean ± SD)
Post (%) (Mean ± SD)
% Change

99.63 ± 51.62
97.13 ± 44.24
−4.38 ± 76.64

91.23 ± 36.24
108.96 ± 61.69
19.74 ± 43.22

0.613
0.525
0.275

RV/TLC (Lt)
Pre (Mean ± SD)
Post (Mean ± SD)
% Change

0.38 ± 0.10
0.36 ± 0.10
10.97 ± 42.01

0.35 ± 0.11
0.37 ± 0.09
11.33 ± 42.68

0.428
0.401
0.052

RV

Pre(%) (Mean ± SD)
Post (%) (Mean ± SD)
% Change

Abbreviations: FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity;
SpO2, peripheral capillary oxygen saturation; MPIS, modified pulmonary index score;
TLC, total lung capacity; RV, residual volume; SGaw, Specific airway conductance.

study that compared the clinical utility of the e-Motion
mesh nebulizer and a conventional jet nebulizer included
patients younger than six years of age with mild asthma
attacks. They found no significant difference between

clinical scores with 2 devices. Similarly, shortened
inhalation time with MN was shown [10]. We did not
compare the inhalation time, but we observed similar
degrees of improvement in lung functions after beta2-
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Table 4. Comparison of adverse effects in mesh and jet nebulizer study groups.
Mesh Group

Jet Group

P*

Pre n (%)

Post n (%)

P

Pre n (%)

Post n (%)

P

Palpitation

3
(9.7)

10
(32.3)

0.016

6
(19.4)

8
(25.8)

0.500

0.774

Shivering

7
(22.6)

9
(29.0)

0.500

8
(25.8)

11
(35.5)

0.375

0.727

Flushing

2
(6.5)

1
(3.2)

1.000

2
(6.5)

4
(12.9)

0.625

0.375

Tremor

5
(16.1)

7
(22.6)

0.125

5
(16.1)

8
(25.8)

0.250

1.000

* Postmesh vs. Postjet

agonist inhalation in both groups. The effectiveness of
both nebulizers was comparable. The long-term use of
different types of nebulizers might influence the outcome.
Dunne and Shortt reported that use of MN was associated
with fewer admissions to the hospital, shorter length of
stay in the emergency department, and a reduction in total
beta2 agonist dose [11].
In previous research, WBP was not used to evaluate
the effectiveness of MN. WBP measurements are a
comparable assessment of lung function to spirometry
and provide more detailed information regarding the lung
volume. Moreover, WBP offers a more sensitive measure
of airway obstruction (sGaw). In our study, the MN group
was comparable with the JN group in pretreatment and
posttreatment values of TLC, RV, RV/TLC, and sGaw.
There was a slight but statistically significant difference
between changes in TLC and RV between the groups,
mainly due to change in TLC.Its clinical significance
requires further investigation.
Inhaled beta2 agonists have several adverse effects,
including palpitation, tachycardia, tremor, and nausea.
These effects are dependent upon age, dose, and route
of administration. Murayama et al. found an increased
heart rate after salbutamol inhalation in both jet and
mesh groups for children older than 2 years of age. For
the children younger than 2 years, the heart rate increment
was not significant. They concluded that the dose of

salbutamol solution might be excessive for the older age
group [10]. In our study, adverse effects were similar in
both nebulizers, but the complaint of palpitation was
significantly higher in the MN group. This difference
may be related to inhalation efficiency and the dose of the
salbutamol. We did not observe heart rate changes before
and after inhalation therapy in either group. The doses of
salbutamol might need to be reconsidered according to the
type of nebulizers.
The routine administration of the first dose of
salbutamol with JN could be a limitation of our study.
The patients were experiencing mild-moderate asthma
attacks and the JNs were used already in daily practice,
so this study design contributed to increased compliance
of parents and children. Also, a double-blind study with
2 groups using either JN or MN might add value to the
research.
There are many marketed nebulizers, creating a
challenge for clinicians to determine which device is the
most suitable for their patients. The therapy choice should
be based on the patients’ characteristics and economic
status. Many patients use these devices incorrectly, so
observation of the patients and proper education is also
an important point. Our study supported that MN is as
effective and safe as JN in the treatment of acute asthma
in children, but further randomized controlled studies are
required to guide clinicians in selection of nebulizers.
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